U.S., April 9 -- ClinicalTrials.gov registry received information related to the study (NCT06916338) titled 'Clinical Study of 18F-Labeled FAPI-04 in PET Imaging of Breast Cancer' on April 01.
Brief Summary: This study aims to evaluate the diagnostic accuracy (sensitivity, specificity, positive/negative predictive value, and overall accuracy) of 18F-FAPI-04 PET imaging in breast cancer for detecting fibroblast activation protein (FAP)-rich lesions. Additionally, the study will longitudinally monitor dynamic changes in FAP expression levels and tumor size during therapy, including chemotherapy, targeted therapy, or immunotherapy.The non-invasive nature of 18F-FAPI-04 PET addresses limitations of traditional biopsy-dependent stromal evaluati...